NORTH CHICAGO, Ill., Oct. 23, 2024 /PRNewswire/ -- U.P. Oncolytics, a company in Rosalind Franklin University's Helix 51 biomedical incubator, has been awarded Orphan Drug designation by the FDA's ...

NORTH CHICAGO, Ill., June 25, 2025 /PRNewswire/ -- UP Oncolytics, a neuro-oncology biotechnology company based in Milwaukee and a spin-out of the Advocate Aurora Research Institute, has received a $75 ...

NORTH CHICAGO, Ill., Jan. 31, 2024 /PRNewswire/ -- Artec Biotech, a company in Rosalind Franklin University's Helix 51 Incubator, is developing a potentially promising treatment for glioblastoma ...

FILE - A model of a DNA molecule is displayed in the New York office of the Sloan-Kettering Institute for Cancer Research on Oct. 18, 1962. The discovery of DNA’s “twisted ladder” structure 70 years ...

$1.2 Million Distributed by Mary Kay Ash Foundation Will Fund Promising Cancer Researchers at Top Universities Advancing Cures For Women-Related Cancers Dr. Howe, an assistant professor of ...

NORTH CHICAGO, Ill., Jan. 23, 2025 /PRNewswire/ -- Rosalind Franklin University of Medicine and Science announced that Monopar Therapeutics is the latest biotech company to join the Helix 51 ...

Rosalind Franklin University is picking up about $9.8 million in funding from the National Institutes of Health for three research projects, the North Chicago life sciences university said in a press ...